Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
about
MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics.Precocious anaphase and expression of Securin and p53 genes as candidate biomarkers for the early detection in areca nut-induced carcinogenesis.Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signallingHuman pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.Securin promotes the identification of favourable outcome in invasive breast cancer.RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.Pituitary tumor-transforming gene and its binding factor in endocrine cancer.PTTG1/securin modulates microtubule nucleation and cell migration.Regulatory effects of miRNA on gastric cancer cells.Molecular characterization of central neurocytomas: potential markers for tumor typing and progression.Prognostic implications of securin expression and sub-cellular localization in human breast cancer.High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer
P2860
Q24617676-1F888E21-6110-4557-8FA3-CEFD98A62FFCQ24642374-64A347E3-56D1-49A7-9B72-A83C6B4CF309Q33619919-53E6B106-68A7-4F41-86E6-5371A49ED8C8Q33835231-89E3F049-CB3D-49D2-AFE5-E3F8D24FD79AQ35495925-18436DD6-0825-44C1-AFDA-92E0F0B91A58Q36053060-77A83626-F82E-4A57-B37A-AF1F00163298Q36924396-19CE3528-C9BD-4EDC-92F6-7DFE03306DF4Q37345354-5EA24120-ED8F-4832-8D88-03B4AB33533CQ37370796-BA08AC32-E5CB-41B2-A655-3447B59F0C3FQ37815569-3F02B072-1657-401B-B776-BF00CC314D23Q39123711-1FF4D4AE-412F-4769-8758-937390A2A33DQ41893722-E7CCA747-B92A-413A-83B5-7F4638C5A265Q48433807-BE9F419C-8452-46E9-B364-82E8D0ECAF6BQ52880311-A3F3AD51-4589-40B2-8F05-858B3DD1C6EDQ54586750-AE13FE39-7EEF-4874-9267-D4482C93F2B6Q55057384-2430BE50-A71E-4472-9240-64F2B6C2A27AQ57462007-F4318596-6121-48B2-953E-7B4A82436B39
P2860
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@ast
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@en
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@nl
type
label
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@ast
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@en
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@nl
prefLabel
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@ast
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@en
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Pituitary tumor-transforming 1 ...... ageal squamous cell carcinoma.
@en
P2093
Alexandru Olaru
Bogdan Paun
Fumiaki Sato
James P Hamilton
John M Abraham
Rachana Agarwal
Stefan David
Stephen J Meltzer
Takatsugu Kan
P2860
P304
P356
10.1158/0008-5472.CAN-07-3043
P407
P577
2008-05-01T00:00:00Z